184441 Disaster Management in Megacities: A Case Study from New York City

Monday, October 27, 2008: 9:15 AM

Linda Young Landesman, DrPH, MSW , Office of Professional Services and Affiliations, New York City Health and Hospitals Corporation, New York, NY
Isaac Weisfuse, MD, MPH , Deputy Commissioner, Division of Disease Control, New York City Department of Health and Mental Hygiene, New York, NY
New York City (NYC), one of the great megacities in North America, is the most densely populated city in the United States (U.S.). One of every 36 people living in the U.S. resides in NYC, with 8.3 million people living in 322 square miles, or 27,000 people per square mile. Although there is a rich and complex medical and public health capacity, NYC confronts daily challenges of ensuring the effective functioning of its infrastructure, protecting the health of the population living in crowded quarters, and delivering emergency services in heavy traffic congestion.

With 67 acute care hospitals and multiples of community-based health care delivery systems, the coordination of preparedness and response is complex, at best, during an emergency. The blackout of 2003 challenged the entire public health and hospital system as it blanketed 85% of New York State with total loss of power for at least 30 hours. Historically, New York City has been a leader in actively implementing principles of public health preparedness. These principles were tested during the August blackout of 2003. We will review the challenges posed by this and other emergencies.

Learning Objectives:
1) To review management principles in dealing with emergencies in a megacity. 2) To illustrate how a megacity in the developed world confronts a common type of emergency.

Keywords: Disasters, Health Departments

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: wrote 6 books on topic
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.